• Policy
• Will a new Alzheimer’s drug be introduced in 20 yrs in KOR?
• by Lee, Tak-Sun Oct 20, 2023 05:31am

• Policy
• HIRA ‘will discuss reimb obesity treatments with MOHW'
• by Lee, Tak-Sun Oct 19, 2023 05:29am

• Policy
• NA calls for prompt reimb of Ilaris during NA audit
• by Lee, Tak-Sun Oct 19, 2023 05:29am

• Policy
• Rep. Young-hee Choi ‘expenses surged after Moon Care’
• by Lee, Tak-Sun Oct 18, 2023 05:49am

• Policy
• Layla+Celecoxib coming soon
• by Lee, Tak-Sun Oct 18, 2023 05:48am

• Policy
• Pharma-Bio Control Tower launched…first meeting next month
• by Lee, Jeong-Hwan Oct 18, 2023 05:48am

• Policy
• Daewoong's new diabetes drug 'Envlo',
• by Lee, Tak-Sun Oct 17, 2023 05:28am

• Policy
• Yuhan’s Leclaza passes DREC review for 1st-line NSCLC
• by Lee, Tak-Sun Oct 16, 2023 05:24am

• Policy
• Regkirona approval is for the Moon care to build up records
• by Lee, Jeong-Hwan Oct 13, 2023 05:30am

• Policy
• NA Rep Kang ‘Increase gov't support to treat breast cancer'
• by Lee, Jeong-Hwan Oct 13, 2023 05:29am